Webcast: Meet Polar BioAnalysis
Register HereIDBS announces Polar BioAnalysis — bringing consistency, quality, and reproducibility to preclinical drug qualification across the development lifecycle.
Polar BioAnalysis expands the capabilities of IDBS Polar, a cloud-based platform that smooths the bumps of biopharmaceutical development – easing the curation of data that CRO’s need to accelerate cycle time and pharma require to deliver drug-to-market.
Join us to learn more about how IDBS delivers best practices in bioanalytical sample management, QC reporting, method execution, ICH M-10 compliance, and more.
Date: Tuesday, 30th March, 2021
Time slots:
10:00 AM EST / 4:00 PM GMT / 5:00 PM CET
Duration: 40 minutes
Graeme Dennis, Commercial Director, Preclinical Biopharma
Graeme Dennis joined IDBS as the Commercial Director, Preclinical Pharma in 2018. Prior to IDBS, Graeme held scientific informatics roles in academia and industry. Graeme is interested in systems that help organizations decouple data from its systems of acquisition and use, enabling to pursue data-driven strategic objectives. He lives in Nashville, Tennessee
Register here
More webinars
The post Webcast – Meet Polar BioAnalysis appeared first on IDBS.